Cannabis stocks – struggling to get high

Cannabis stocks – struggling to get high
Greenfern will soon start writing clinical trial protocols for a low dose cannabidiol medication. (Image: Getty)
Brian Gaynor
The three NZX-listed cannabis companies – Cannasouth, Greenfern Industries and Rua Bioscience – are struggling to gain momentum, particularly as far as their share price performances are concerned.All three stocks are trading well below their issue price.This will be a major disappointment to Sharesies investors because they have dominated trading activity in all three companies.Sharesies investors make up 61% of all Cannasouth on-market trades by number since listing, 70.5% of Greenfern’s trades, and 64.3% of Rua Bioscience&r...

More Opinion

Risk on and off
Opinion

David Chaplin: Risk on and off

Volatility is just part of the furniture.

The dirty money delusion
Law & Regulation

Dileepa Fonseka: The dirty money delusion

The problem isn’t children not getting bank accounts, it’s adults being debanked.

Dileepa Fonseka 21 Jul 2025
The Stock Series: Strategy and Tesla
Opinion

Simon Robertson: The Stock Series: Strategy and Tesla

Right now you want to own some stocks with high volatility.

Simon Robertson 19 Jul 2025
Banks class action: the lawyers blinked first
Policy Opinion

Pattrick Smellie: Banks class action: the lawyers blinked first

Class action funders show their hand with pre-emptive settlement offer.

Pattrick Smellie 17 Jul 2025